DK1644740T3 - Vurdering af skeletal vækst ved anvendelse af målinger af NT-CNP-peptider - Google Patents
Vurdering af skeletal vækst ved anvendelse af målinger af NT-CNP-peptiderInfo
- Publication number
- DK1644740T3 DK1644740T3 DK04748820.0T DK04748820T DK1644740T3 DK 1644740 T3 DK1644740 T3 DK 1644740T3 DK 04748820 T DK04748820 T DK 04748820T DK 1644740 T3 DK1644740 T3 DK 1644740T3
- Authority
- DK
- Denmark
- Prior art keywords
- growth
- cnp
- plasma
- skeletal growth
- provides
- Prior art date
Links
- 230000009645 skeletal growth Effects 0.000 title abstract 3
- 238000005259 measurement Methods 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000012544 monitoring process Methods 0.000 abstract 2
- 102000012421 C-Type Natriuretic Peptide Human genes 0.000 abstract 1
- 101800000060 C-type natriuretic peptide Proteins 0.000 abstract 1
- 208000004286 Osteochondrodysplasias Diseases 0.000 abstract 1
- 239000012491 analyte Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 208000037824 growth disorder Diseases 0.000 abstract 1
- 210000004349 growth plate Anatomy 0.000 abstract 1
- 230000009931 harmful effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ52652603 | 2003-06-17 | ||
| PCT/NZ2004/000125 WO2004111653A1 (en) | 2003-06-17 | 2004-06-17 | Assessment of skeletal growth using measurements of nt-cnp peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1644740T3 true DK1644740T3 (da) | 2011-02-21 |
Family
ID=33550523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04748820.0T DK1644740T3 (da) | 2003-06-17 | 2004-06-17 | Vurdering af skeletal vækst ved anvendelse af målinger af NT-CNP-peptider |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7919255B2 (da) |
| EP (1) | EP1644740B1 (da) |
| AT (1) | ATE490469T1 (da) |
| CA (1) | CA2570398C (da) |
| DE (1) | DE602004030342D1 (da) |
| DK (1) | DK1644740T3 (da) |
| WO (1) | WO2004111653A1 (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004105575A2 (en) * | 2003-05-29 | 2004-12-09 | Trustee Of Darmouth College | A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
| HUE055861T2 (hu) | 2004-04-21 | 2021-12-28 | Alexion Pharma Inc | Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez |
| US7767404B2 (en) * | 2005-08-16 | 2010-08-03 | Chipotle Business Group, Inc. | Apparatus and method for single-step immunosorbent assay for single and multiple analytes |
| US8735142B2 (en) * | 2005-08-16 | 2014-05-27 | Chipotle Business Group, Inc. | Systems and methods for immunosorbent assays for single and multiple analytes |
| HRP20161739T1 (hr) | 2009-05-20 | 2017-03-10 | Biomarin Pharmaceutical Inc. | VARIJANTE NATRIURETIČNOG PEPTIDA C-tipa |
| CA2823066A1 (en) | 2010-12-27 | 2012-07-05 | Alexion Pharma International Sarl | Compositions comprising natriuretic peptides and methods of use thereof |
| US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| CN104937420B (zh) * | 2012-08-13 | 2018-07-03 | 奥塔哥创业有限公司 | 作为血管疾病和妊娠并发症的生物标记的NT-proCNP |
| US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
| CA2967851C (en) | 2014-12-05 | 2024-02-27 | Alexion Pharmaceuticals, Inc. | Treating seizure with recombinant alkaline phosphatase |
| US10603361B2 (en) | 2015-01-28 | 2020-03-31 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
| RU2745528C2 (ru) | 2015-08-17 | 2021-03-26 | Алексион Фармасьютикалз, Инк. | Производство щелочных фосфатаз |
| WO2017058822A1 (en) | 2015-09-28 | 2017-04-06 | Alexion Pharmaceuticals, Inc. | Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia |
| WO2017074466A1 (en) | 2015-10-30 | 2017-05-04 | Alexion Pharmaceuticals, Inc. | Methods for treating craniosynostosis in a patient |
| EP3426286A4 (en) | 2016-03-08 | 2019-12-04 | Alexion Pharmaceuticals, Inc. | PROCESS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN |
| EP3436020A4 (en) | 2016-04-01 | 2019-12-25 | Alexion Pharmaceuticals, Inc. | METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS |
| JP7613826B2 (ja) | 2016-04-01 | 2025-01-15 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | アルカリホスファターゼによって筋力低下を治療すること |
| US10988744B2 (en) | 2016-06-06 | 2021-04-27 | Alexion Pharmaceuticals, Inc. | Method of producing alkaline phosphatase |
| WO2017218911A1 (en) | 2016-06-17 | 2017-12-21 | Abbott Laboratories | BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF) |
| EP3500289B1 (en) | 2016-08-18 | 2024-10-09 | Alexion Pharmaceuticals, Inc. | Asfotase alfa for use in treating tracheobronchomalacia |
| CA3057502A1 (en) | 2017-03-31 | 2018-10-04 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia (hpp) in adults and adolescents |
| JP2021519590A (ja) | 2018-03-30 | 2021-08-12 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 糖タンパク質の製造 |
| JP2021534111A (ja) | 2018-08-10 | 2021-12-09 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | アルカリホスファターゼを用いて神経線維腫症１型および関連状態を治療する方法 |
| US12433938B2 (en) | 2019-12-09 | 2025-10-07 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| AU2022218782A1 (en) | 2021-02-12 | 2023-08-17 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| CN119619532A (zh) * | 2024-10-30 | 2025-03-14 | 中国科学院动物研究所 | 一种用于评价和/或预测骨骼发育状况的试剂盒和方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT407580B (de) | 1999-08-20 | 2001-04-25 | Biomedica Gmbh | Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay |
| US20030219734A1 (en) * | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
-
2004
- 2004-06-17 CA CA2570398A patent/CA2570398C/en not_active Expired - Fee Related
- 2004-06-17 DE DE602004030342T patent/DE602004030342D1/de not_active Expired - Lifetime
- 2004-06-17 DK DK04748820.0T patent/DK1644740T3/da active
- 2004-06-17 AT AT04748820T patent/ATE490469T1/de not_active IP Right Cessation
- 2004-06-17 WO PCT/NZ2004/000125 patent/WO2004111653A1/en not_active Ceased
- 2004-06-17 US US10/561,119 patent/US7919255B2/en not_active Expired - Fee Related
- 2004-06-17 EP EP04748820A patent/EP1644740B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004111653A1 (en) | 2004-12-23 |
| DE602004030342D1 (de) | 2011-01-13 |
| ATE490469T1 (de) | 2010-12-15 |
| US7919255B2 (en) | 2011-04-05 |
| EP1644740B1 (en) | 2010-12-01 |
| CA2570398C (en) | 2020-05-12 |
| EP1644740A4 (en) | 2007-12-12 |
| CA2570398A1 (en) | 2004-12-23 |
| US20070292966A1 (en) | 2007-12-20 |
| EP1644740A1 (en) | 2006-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1644740T3 (da) | Vurdering af skeletal vækst ved anvendelse af målinger af NT-CNP-peptider | |
| TW200745543A (en) | System and methods for providing corrected analyte concentration measurements | |
| TW200413718A (en) | Method and system for determining the acceptability of signal data collected from a prothrombin time test strip | |
| NO20063816L (no) | Systemer og fremgangsmater for avfoling av blodglykose | |
| Bhasin et al. | The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders | |
| EP2042865A3 (en) | Systems and methods for distinguishing between a control solution and a physiological sample | |
| Castanheira et al. | Predicting cardiometabolic disturbances from waist-to-height ratio: findings from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) baseline | |
| Kang et al. | Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine | |
| KR20080003419A (ko) | 전기화학적 분석대상물 검출 동안에 비정상적인 경로의검출을 위한 방법 및 장치 | |
| Wang et al. | Characterization of human plasma proteome dynamics using deuterium oxide | |
| WO2005119234A3 (en) | Measuring device and methods for use therewith | |
| JP2000275163A5 (ja) | 粒子分析装置および自動粒子分析方法 | |
| NO20045129L (no) | System og fremgangsmate for maling av blodglukose | |
| EP1312919A3 (en) | Sample volume metering apparatus | |
| RU2012103000A (ru) | Способ и система для тестирования аналита | |
| BRPI0814202A2 (pt) | Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador | |
| MXPA02010106A (es) | Determinacion de suficiencia de volumen de muestra en dispositivos biosensores. | |
| DE60238814D1 (de) | Integriertes blutprobemessgerät mit teststreifen | |
| BR112013005442A2 (pt) | método de medição de analito e sistema com compensação de hematócrito | |
| Kim et al. | Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniques | |
| Faix et al. | Progress in standardizing and harmonizing thyroid function tests | |
| KR20130066841A (ko) | 당화혈색소 센서스트립, 당화혈색소 측정장치 및 이를 이용한 당화혈색소 측정방법 | |
| MX2012007009A (es) | Método para diagnosticar un tumor maligno. | |
| Frank et al. | Performance of the CONTOUR® TS blood glucose monitoring system | |
| CN106338596A (zh) | 一种健康监控方法、装置及电子设备 |